2006 NF Consortium for NF1, NF2 and Schwannomatosis

2006 NF1、NF2 和神经鞘瘤病联盟

• 批准号: 7162767
• 负责人: VIJAYA RAMESH
• 金额: $ 3.05万
• 依托单位: CHILDREN'S TUMOR FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-07-15 至 2007-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7162767
• 关键词: meeting /conference /symposium; neurofibromatosis

DESCRIPTION (provided by applicant): This application requests funding support for the 2006 annual meeting of the Children's Tumor Foundation International Consortium for the Molecular and Cell Biology of NF1, NF2 and Schwannomatosis. The Meeting will be held June 4-7, 2006, at the Hotel Jerome in Aspen, Colorado. This annual meeting has had a fruitful history since its inception in 1985, and it plays a lynchpin role as the premier annual gathering of researchers and clinicians in the NF community. The meeting is a forum for research information exchange and discussion for researchers from around the world, and has traditionally fostered collaboration, consensus building, and advances in translational research culminating in clinical trials. This is a time of tremendous advances in NF research on many fronts from basic through clinical, and this is reflected in the theme of the 2006 meeting - "Progress: From Bench to Bedside". Five individual sessions will take the Consortium from molecular mechanisms of NF through translational models to clinical therapies. Speakers will include both junior and senior researchers. In keeping with the bench to bedside theme, for the first time select sessions will include a few words from a patient advocate whose life is affected by NF. Each session will also include a keynote address by a leading investigator from outside of NF research to open up broad ranging discussions. Competitive travel awards will bring young investigators for oral presentations, and 2 poster sessions will allow investigators to present their work to the NF community. In 2006 we are taking two new approaches in order to increase the visibility of this meeting and of the state of NF research. Firstly to increase industry awareness of NF we will seek fiscal sponsorship for this meeting from a large number of pharmaceutical companies. Incentive sponsorships will be offered at diamond, platinum, gold and silver levels. Secondly, the co-chairs and the Foundation will work together to seek publication of a Consortium Report in a peer-reviewed journal. This will promote to the research community at large the status of NF research, the link with other cancers and neurological disorders and the key barriers to be addressed.

描述(申请人提供)：本申请申请资助儿童肿瘤基金会NF1、NF2和神经鞘瘤病的分子和细胞生物学国际联合会2006年年会。会议将于2006年6月4日至7日在科罗拉多州阿斯彭的杰罗姆酒店举行。自1985年成立以来，这一年度会议已经有了丰硕的历史，它作为核心病界研究人员和临床医生的首要年度聚会发挥了关键作用。会议是来自世界各地的研究人员交流和讨论研究信息的论坛，传统上促进合作、建立共识和推动转化性研究的进展，最终达到临床试验的目的。这是一个从基础到临床在许多方面都取得了巨大进步的时期，这反映在2006年会议的主题--“进步：从长凳到床边”。五个单独的会议将使该联盟从神经营养因子的分子机制通过翻译模型到临床治疗。演讲者包括初级和高级研究人员。为了与长凳到床边的主题保持一致，精选会议将首次包括一位生活受到核因子影响的患者权益倡导者的几句话。每一次会议还将包括一位来自核研究之外的领先研究人员的主旨演讲，以开启广泛的讨论。竞争激烈的旅行奖项将带来年轻的研究人员进行口头演示，2个海报会议将允许调查人员向NF社区展示他们的工作。2006年，我们将采取两种新的方法，以提高本次会议的知名度和核研究的状况。首先，为了提高业界对NF的认识，我们将为这次会议寻求大量制药公司的财政赞助。奖励赞助将提供钻石、白金、黄金和白银级别的赞助。第二，联合主席和基金会将共同努力，争取在同行评议的期刊上发表联合会的报告。这将向广大研究界宣传核因子研究的现状、与其他癌症和神经疾病的联系以及需要解决的关键障碍。